| Bioactivity | Peliglitazar is a dual α/γ PPAR activator. |
| Target | α/γ PPAR |
| In Vivo | Peliglitazar, is a novel dual α/γperoxisome proliferator-activated receptor (PPAR) activator. It has been shown that Peliglitazar has both glucose and lipid-lowering effects when tested in animal models of diabetes and dyslipidemia[1]. MCE has not independently confirmed the accuracy of these methods. They are for reference only. |
| CAS | 331744-64-0 |
| Formula | C30H30N2O7 |
| Molar Mass | 530.57 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Wang L, et al. Metabolism and disposition of 14C-labeled peliglitazar in humans. Drug Metab Dispos. 2011 Feb;39(2):228-38. |